Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF, FRA:T2X) could be on the cusp of a re-rating as it moves towards becoming a multi-asset producer, according to Shore Capital.
In a 20-page note, the broker initiated coverage with a 'buy' rating and a 125p price target, implying around 55% upside from the close at the end of last week, citing progress at the Douta gold project in Senegal and strong cash generation from its Segilola mine in Nigeria.
EnWave Corp (TSX-V:ENW, OTC:NWVCF, FRA:E4U) announced a new commercial licensing agreement with The Dry Hub to deploy its proprietary drying technology in Egypt.
The agreement grants The Dry Hub exclusive rights within Egypt to use EnWave’s patented REV (Radiant Energy Vacuum) technology for drying selected fruits, vegetables, and herbs. As part of the deal, The Dry Hub will purchase a 10kW REV machine to begin commercial-scale production at its facility.
Sonoro Gold Corp (TSX-V:SGO, OTCQB:SMOFF, FRA:23SP) announced that it has filed an updated technical report outlining a revised mineral resource estimate and preliminary economic assessment (PEA) for its Cerro Caliche gold project in Sonora, Mexico.
The report evaluates the potential for an open-pit, heap-leach mining operation with an estimated 10-year life of mine.
Graphene Manufacturing Group Ltd (TSX-V:GMG, OTCQX:GMGMF) said on Wednesday its graphene aluminium-ion battery technology has demonstrated improved performance metrics, including the ability to charge in as little as six minutes.
The company, working with the University of Queensland under a joint development agreement with mining major Rio Tinto and with support from the Battery Innovation Center in the US, said its G+A Cells showed gains in energy density and fast-charging capability compared with lithium titanate oxide (LTO) batteries.
Medicus Pharma (NASDAQ:MDCX) announced plans to present new early-stage clinical data on its investigational drug candidate, Teverelix, at the American Association of Clinical Endocrinology (AACE) Annual Meeting 2026 in Las Vegas later this month.
The company said the presentation will include results from two Phase 1 studies evaluating Teverelix, a long-acting gonadotropin-releasing hormone (GnRH) antagonist being developed for hormone-related conditions. Potential applications include women’s health disorders such as endometriosis and uterine fibroids.
Reconnaissance Energy Africa Ltd (TSX-V:RECO, OTCQX:RECAF, FRA:0XD) said it expects to complete production testing at its Kavango West 1X discovery in Namibia by the end of June, a key milestone that could underpin a potential development decision as the company accelerates exploration across southern and West Africa.
The oil and gas explorer said optimized zone production testing at the discovery well is set to begin in early-to-mid May, with six hydrocarbon-bearing zones to be evaluated sequentially over roughly 420 metres of reservoir.
Power Metallic Mines Inc (TSX-V:PNPN, FRA:IVV1, OTCQB:PNPNF) has released assay results from its winter 2026 drilling campaign, highlighting continued mineralization at its Lion zone at its Nisk polymetallic project in Quebec and progress toward a planned mineral resource estimate (MRE).
The company reported that drill hole PML-26-050 intersected 27.1 metres grading 2.17% copper equivalent (CuEq), including a higher-grade interval of 4.76 metres at 10.43% CuEq.
Ceres Power Holdings PLC (LSE:CWR, OTC:CPWHF) shares rose 14.5% after the group launched a new solid oxide platform aimed at fast-growing demand from data centres and other energy-intensive users.
The company said its Endura system is designed to deliver onsite power more quickly and at lower cost, with installations possible in months rather than years.
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) shares rose as much as 8% on Wednesday after receipt of Clinical Trial Authorisation from the UK medicines regulator for its POLB 001 TOPICAL study.
Cavendish said the milestone represents a key de-risking event and clears the final hurdle ahead of patient screening.
Iofina PLC (AIM:IOF, OTC:IOFNF) shares rose as much as 12% in morning trading after the iodine producer reported record first-quarter output and lifted its first-half production guidance, citing new capacity and unusually favourable operating conditions.
The company produced 178.9 metric tonnes of crystalline iodine from its eight IOsorb plants in Oklahoma in the first quarter of 2026, up 44% from 124.1 metric tonnes in the same period last year.
Silverbullet Data Services Group PLC (LSE:SBDS) saw its shares rise 10.5%, to 21p, after revealing its first period of positive EBITDA in the first quarter of its new financial year.
It also posted a 22% rise in revenue and improved margins, pushing the AIM-listed marketing technology group ahead of internal expectations.
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has locked in the timing for its March quarter update and investor briefing, while reminding shareholders that its current capital raising is approaching its closing date.
The company will release its Q3 FY26 results on April 20, followed by an investor webinar on April 21, where management will outline quarterly performance and recent developments.
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the AIM-listed clinical-stage biopharmaceutical company, has received clinical trial authorisation from the UK Medicines and Healthcare products Regulatory Agency for its TOPICAL trial, with interim data expected this summer.
The trial is investigating POLB 001, which is being developed as a potential first-approved preventative therapy for cytokine release syndrome (CRS), a serious immune reaction triggered by cancer immunotherapies, including CAR T-cell therapies and bispecific antibodies.
Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF, FRA:T2X) has kept full-year guidance in place after pouring 20,256 ounces of gold in the first quarter from its Segilola mine in Nigeria, as the West Africa-focused producer ended March with US$154 million in cash and pushed ahead with drilling across its wider portfolio.
The company sold 15,417 ounces in the quarter at an average realised gold price of US$4,829 an ounce. Including 4,000 ounces of bullion inventory, Thor said it had an adjusted net cash position of US$173 million at quarter-end, underlining the balance sheet strength built during 2025.
Anglo Asian Mining Plc (LSE:AAZ, OTC:AGXKF, FRA:A4A) told investors that first-quarter copper production surged almost sevenfold as its Demirli mine helped drive a sharp step-up in output, while stronger sales and lower debt pushed the group deeper into net cash.
The Azerbaijan-focused producer turned out 3,711 tonnes of copper in the three months to 31 March, up from 534 tonnes a year earlier.
Iofina PLC (AIM:IOF, OTC:IOFNF), the AIM-listed iodine producer, has reported record first-quarter production and upgraded its first-half guidance after new capacity and favourable operating conditions drove a 44% year-on-year increase in output.
The company produced 178.9 metric tonnes of crystalline iodine from its eight IOsorb plants in Oklahoma during the first quarter of 2026, compared with 124.1 metric tonnes in the same period last year.
Elevate Uranium Ltd (ASX:EL8, OTCQX:ELVUF) has lifted the mineral resource base at its Koppies Uranium Project in Namibia to 76.2 million pounds of U3O8 after declaring a maiden inferred resource at the Namib IV deposit.
The new Namib IV mineral resource estimate comes in at 29.5 million tonnes grading 155 parts per million eU3O8 for 10.1 million pounds of U3O8 at a 100ppm cut-off grade, adding a fresh resource centre to the broader Koppies project in the Erongo region.
Riversgold Ltd (ASX:RGL, FRA:RGV, OTC:RVSGF) has delivered a new round of strong drilling results from its Northern Zone Gold Project near Kalgoorlie, with high-grade intercepts and shallow mineralisation continuing to extend the footprint of the system.
Assays from 31 aircore drillholes have returned grades of up to 71 g/t gold, alongside multiple broad intercepts that rank among the best results recorded at the project to date.
AuMEGA Metals Ltd (ASX:AAM, TSX:AUM, OTCQB:AUMMF, FRA:FRA: MA30) has completed a ~C$30.1 million (AU$31.1M) financing, strengthening its balance sheet and positioning the company to accelerate exploration across its Newfoundland gold projects in 2026.
The raise, completed in two tranches, saw approximately C$5.4 million secured in early March followed by a further C$24.7 million after shareholder approval in April, marking what management described as a transformational step for the company’s funding capacity and growth outlook.
Novo Resources Corp (TSX:NVO, OTCQX:NSRPF, ASX:NVO, FRA:1NOR) has appointed experienced geologist Rohan Williams as general manager of exploration, effective April 15, 2026.
Williams, who replaces Karen de Luca after eight years of dedicated service, brings more than 30 years of experience across exploration, feasibility, open pit and underground mining, and resource development in Australia, Africa and Southeast Asia.
Orthocell Ltd (ASX:OCC, OTC:ORHHF) has secured a significant expansion of its US market opportunity, gaining approval for its Remplir nerve repair device to be used across the US Department of Defense (DoD) and Veterans Affairs (VA) hospital networks.
The approval opens the door to 221 facilities — 51 military hospitals and 170 VA medical centres — adding to Orthocell’s US commercial footprint as it builds on recent regulatory clearance and early sales traction.
Terrain Minerals Ltd (ASX:TMX, OTC:TMXAF, FRA:T4Y) has delivered a fresh round of high-grade gold results from drilling at its Lightning prospect, with new assays confirming continuity of mineralisation along strike and at depth while expanding the scale of the system ahead of a maiden resource targeted for mid-2026.
The results come from a 29-hole reverse circulation (RC) program completed between November 2025 and February 2026 at the 100%-owned Smokebush project in Western Australia’s Murchison region, where drilling is increasingly pointing to a broader and more complex gold system than previously understood.